Baymax Research, Inc.
Country not established
- Devices
- 1
What Baymax Research, Inc. makes
Baymax Research, Inc. makes the MiMo(TM) Negative Pressure Wound Therapy System, a medical device designed for wound care management using controlled subatmospheric pressure.
The MiMo(TM) Negative Pressure Wound Therapy System is classified as a Class II device and is listed in the FDA 510(k) registry; the company is based in the United States.
Catalogue
MiMo(TM) Negative Pressure Wound Therapy System Ref K181929
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Baymax Research, Inc. have in the registry?
The registry currently lists 1 device for Baymax Research, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Baymax Research, Inc.'s devices?
Among its 1 most recently registered device, Baymax Research, Inc. has devices listed in FDA 510(k) (1 device).
What risk classes do Baymax Research, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Baymax Research, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Baymax Research, Inc. in the registry?
The most recently registered devices listed for Baymax Research, Inc. include MiMo(TM) Negative Pressure Wound Therapy System.